Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIK Treatment in HCC After Radical Resection
NCT00769106Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2008
- Primary completion
- Sep 2014
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 3 trial of unmodified CIK in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Started Jun 2008; status: completed.
02
Drugs
unmodified CIK
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00769106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769106.